Filter
455
Text search:
antimalarial
drugs
Featured
Recommendations
54
New Publications
154
Language
Document type
No document type
256
Studies & Reports
70
Guidelines
57
Manuals
24
Training Material
16
Strategic & Response Plan
14
Fact sheets
9
Resource Platforms
4
Infographics
3
Situation Updates
2
Countries / Regions
Uganda
26
Global
26
India
24
Kenya
22
Sierra Leone
19
Liberia
18
Nigeria
17
Malawi
15
Zambia
14
Rwanda
14
Ghana
13
Tanzania
13
Ethiopia
12
Africa
11
Senegal
9
Latin America and the Carribbean
8
Nepal
6
Cambodia
6
Zimbabwe
5
Philippines
5
South Africa
5
Mozambique
5
South–East Asia Region
5
Cameroon
4
Thailand
4
Bangladesh
4
Vietnam
4
South Sudan
3
Eswatini/ Swaziland
3
Myanmar / Burma
3
Asia
3
Laos
3
Burkina Faso
2
Somalia
2
Pakistan
2
China
2
Botswana
2
West and Central Africa
2
North America
2
Congo, Democratic Republic of
1
Mali
1
Lebanon
1
Chad
1
Indonesia
1
Namibia
1
Brazil
1
Libya
1
Sri Lanka
1
East and Southern Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Solomon Islands
1
Venezuela
1
Southern Africa
1
Timor Leste/ East Timor
1
Authors & Publishers
Publication Years
Category
Countries
255
Clinical Guidelines
46
Women & Child Health
29
Capacity Building
19
Public Health
19
Key Resources
13
Pharmacy & Technologies
12
Toolboxes
Malaria
76
Pharmacy
29
AMR
20
Ebola & Marburg
15
HIV
13
COVID-19
6
Caregiver
5
NTDs
5
Health Financing Toolbox
5
Rapid Response
4
2.0 Rapid Response
3
Polio
2
Conflict
2
Mental Health
2
Disability
1
Cholera
1
Natural Hazards
1
Zika
1
TB
1
Global Health Education
1
Planetary Health
1
Pillar 3 of the Global technical strategy for malaria 2016–2030 calls for the transformation of malaria surveillance into a core intervention in all malaria-endemic countries, as well as in countries which have eliminated malaria but remain susceptible to re-establishment of transmission. This ref
...
Thematic brief. Climate change and malaria are two defining challenges of our generation. Both affect disproportionately the
poorest and the most vulnerable, especially in Africa, and may further jeopardize human wellbeing in the future
The framework recommends expanded coverage of malaria diagnostic and treatment services, intensified vector control to drive down transmission, strengthened malaria surveillance, and increased transborder collaboration, especially in terms of efforts to control the sale and use of artemisinin monoth
...
This global guidance was developed to support malaria-free countries and those that are close to malaria elimination to prevent re-establishment. The document outlines key concepts and principles for preventing re-establishment and provides guidance on strategies, interventions, planning and managem
...
Take Action on Antimicrobial Resistance. For students in high school.
This AMR booklet is designed to inform high school students on AMR and how they can prevent it on a personal level. It is a brief document that has the potential to capture their interest as they learn from it.
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t
...
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para
...
BMC Medicine (2015) 13:42 DOI 10.1186/s12916-014-0263-6
Malawi Health Sector Strategic Plan 2011 - 2016
recommended
Moving towards equity and quality
Accessed November 2017
Clinical Guidance across the continuum of care
Chapter 8_ARV Guidelines
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was
...
